Quantitative determination of sildenafil (Viagra®) and its metabolite (UK-103,320) in fluid and tissue specimens obtained from six aviation fatalities

Journal of Analytical Toxicology

Volumn 30, Issue 1, 2006, Pages 14-20

  Lewis, Russell J ^a   Johnson, Robert D ^a   Blank, C LeRoy ^b  

^a CIVIL AEROSPACE MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; UK 103320; UNCLASSIFIED DRUG; PIPERAZINE DERIVATIVE; PYRIMIDINONE DERIVATIVE; VASODILATOR AGENT;

AIRCRAFT ACCIDENT; ARTICLE; ATMOSPHERIC PRESSURE; AUTOPSY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SYNTHESIS; HUMAN; HUMAN TISSUE; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TISSUE SLICE; BODY FLUID; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; FORENSIC MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; METHODOLOGY; REPRODUCIBILITY; TISSUE DISTRIBUTION; VALIDATION STUDY;

ACCIDENTS, AVIATION; BODY FLUIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FORENSIC MEDICINE; HUMANS; MALE; PIPERAZINES; PYRIMIDINONES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TISSUE DISTRIBUTION; VASODILATOR AGENTS;

EID: 33646189207     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/30.1.14     Document Type: Article

References (22)

1. R.A. Kloner and R.M. Zusman. Cardiovascular effects of sildenafil citrate and recommendations for its use. Am. J. Cardiol. 84: 11N-17N (1999).
2. C. de Mey. Opportunities for the treatment of erectile dysfunction by modulation of the NO axis - alternatives to sildenafil citrate. Curr. Med. Res. Opin. 14: 187-202 (1998).
3. J. Henion, E. Brewer, and G. Rule. Sample preparation for LC/MS/MS: Analyzing biological and environmental samples. Anal. Chem. 70: 650A-656A (1998).
4. E.P. Krenzelok. Sildenafil: clinical toxicology profile. J. Toxicol. Clin. Toxicol. 38: 645-651 (2000).
5. R.B. Moreland, I.I. Goldstein, N.N. Kim, and A. Traish. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor. Trends Endocrinol. Metab. 10: 97-104 (1999).
6. G. Altiokka, Z. Atkosar, E. Sener, and M. Tuncel. FIA of sildenafil citrate using UV-detection. J. Pharm. Biomed. Anal. 25: 339-342 (2001).
7. H.D. Langtry and A. Markham. Sildenafil: a review of its use in erectile dysfunction. Drugs 57: 967-989 (1999).
8. J.J. Berzas, J. Rodriquez, M.J. Villasenor, A.M. Contento, and M.P. Cabello. Validation of a capillary gas chromatographic method for the determination of sildenafil citrate in its pharmaceutical formulations (Viagra). Experimental design for evaluating the ruggedness of the method. Chromatographia 55: 601-606 (2002).
9. Pfizer. U.S. prescribing information. Viagra: compound data sheet, 1999.
10. C.K. Jeong, H.Y. Lee, M.S. Jang, W.B. Kim, and H.S. Lee. Narrowbore high-performance liquid chromatography for the simultaneous determination of sildenafil and its metabolite UK-103,320 in human plasma using column switching. J. Chromatogr. B 752: 141-147 (2001).
11. J.D. Cooper, D.C. Muirhead, J.E. Taylor, and P.R. Baker. Development of an assay for the simultaneous determination of sildenafil (Viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography. J. Chromatogr. B 701: 87-95 (1997).
12. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 6th ed. Biomedical Publications, Foster City, CA, 2002.
13. R.A. Kloner and J.P. Jarow. Erectile dysfunction and sildenafil citrate and cardiologists. Am. J. Cardiol. 83: 576-582, A577 (1999).
14. F.T. Fraunfelder and A.M. Laties. Visual side effects possibly associated with Viagra. J. Toxicol. Cut. Ocular Toxicol. 19: 21-25 (2000).
15. TOXI-NEWS. Sildenafil (Viagra). TOXI-LAB, Irvine, CA. 18: 1 (1999).
16. D.J. Borrillo. Dangers of viagra use in pilots. Fed. Air Surg. Med. Bull. 98: 9-10 (1998).
17. V. Dumestre-Toulet, V. Cirimele, S. Gromb, T. Belooussoff, D. Lavault, B. Ludes, and P. Kintz. Last performance with VIAGRA: post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample. Forensic Sci. Int. 126: 71-76 (2002).
18. W. Weinmann, M. Bohnert, A. Wiedemann, M. Renz, N. Lehmann, and S. Pollak. Post-mortem detection and identification of sildenafil (Viagra) and its metabolites by LC/MS and LC/MS/MS. Int. J. Legal Med. 114: 252-258 (2001).
19. R.D. Johnson, R.J. Lewis, D.V. Canfield, and C.L. Blank. Accurate assignment of ethanol origin in postmortem urine: liquid chromatographic-mass spectrometric determination of serotonin metabolites. J. Chromatogr. B 805: 223-234 (2004).
20. D.N. Umrani and R.K. Goyal. Pharmacology of sildenafil citrate. Indian J. Physiol. Pharmacol. 43: 160-164 (1999).
21. Physicians' Desk Reference, 57th ed. Thompson PDR, Montvale, NJ, 2003.
22. D.K. Walker, M.J. Ackland, G.C. James, G.J. Muirhead, D.J. Rance, P. Wastall, and P.A. Wright. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 29: 297-310 (1999).